Acadia Pharmaceuticals
Acadia Pharmaceuticals develops and markets medicines for central nervous system disorders and rare diseases, including NUPLAZID for Parkinson's disease psychosis and DAYBUE for Rett syndrome.
Key facts
| CAGE Code | 5LB84 |
|---|---|
| Legal Name | ACADIA Pharmaceuticals Inc. |
| Company Operating Status | Active |
| Full Address | 12830 EL CAMINO REAL #400 SAN DIEGO, CA 92130 UNITED STATES |
| Stock Symbol | ACAD |
| Ticker Symbol | ACAD |
| Wellfound ID | acadia-pharmaceuticals |
| Wikidata ID | Q4671580 |
Contact details
Email and phone for Acadia Pharmaceuticals are available to signed-in members of CliffBio.
Sign in to view